{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:29:53Z","timestamp":1794274193786,"version":"4.9.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1053\/j.seminhematol.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:52:27Z","timestamp":1715133147000},"page":"212-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The biology of classical Hodgkin lymphoma"],"prefix":"10.1053","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-5261","authenticated-orcid":false,"given":"Samuel","family":"Kosydar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1053\/j.seminhematol.2024.05.001_bib0001","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","article-title":"Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment","volume":"29","author":"Steidl","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0002","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular biology of Hodgkin lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"issue":"21","key":"10.1053\/j.seminhematol.2024.05.001_bib0003","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2017-06-781989","article-title":"Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma","volume":"130","author":"Liu","year":"2017","journal-title":"Blood"},{"issue":"23","key":"10.1053\/j.seminhematol.2024.05.001_bib0004","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","article-title":"Hodgkin lymphoma","volume":"6","author":"Connors","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"51","key":"10.1053\/j.seminhematol.2024.05.001_bib0006","doi-asserted-by":"crossref","first-page":"20729","DOI":"10.1073\/pnas.1312509110","article-title":"Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells","volume":"110","author":"Rengstl","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.05.001_bib0007","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.05.001_bib0008","first-page":"133","article-title":"On the pathological changes in Hodgkin's disease, with especial reference to its relation to tuberculosis","volume":"10","author":"Reed","year":"1902","journal-title":"Johns Hopkins Hosp Rep"},{"issue":"23","key":"10.1053\/j.seminhematol.2024.05.001_bib0009","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","article-title":"Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development","volume":"91","author":"K\u00fcppers","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J Exp Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0011","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1365-2141.2001.02818.x","article-title":"Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin's disease-derived cell lines","volume":"113","author":"Irsch","year":"2001","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1053\/j.seminhematol.2024.05.001_bib0012","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1158\/0008-5472.CAN-06-1992","article-title":"Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma","volume":"66","author":"Mart\u00edn-Subero","year":"2006","journal-title":"Cancer Res"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0013","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V95.3.1023.003k07_1023_1031","article-title":"Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease","volume":"95","author":"Kanzler","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.05.001_bib0014","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.immunol.16.1.471","article-title":"The origin of Hodgkin and Reed\/Sternberg cells in Hodgkin's disease","volume":"16","author":"K\u00fcppers","year":"1998","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin's lymphoma","volume":"9","author":"K\u00fcppers","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminhematol.2024.05.001_bib0016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.4.110807.092209","article-title":"Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma","volume":"4","author":"Schmitz","year":"2009","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.05.001_bib0017","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3121\/cmr.2010.891","article-title":"PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms","volume":"8","author":"Desouki","year":"2010","journal-title":"Clin Med Res"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0018","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/bjh.15614","article-title":"Diagnosis of Hodgkin lymphoma in the modern era","volume":"184","author":"Wang","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0019","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1309\/AJCPW3UN9DYLDSPB","article-title":"Flow cytometry can diagnose classical Hodgkin lymphoma in lymph nodes with high sensitivity and specificity","volume":"131","author":"Fromm","year":"2009","journal-title":"American Journal of Clin Pathol"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5858\/arpa.2020-0795-OA","article-title":"Role of flow cytometric immunophenotyping for classic Hodgkin lymphoma in small biopsy and cytology specimens","volume":"146","author":"Chan","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.05.001_bib0021","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.05.001_bib0022","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","article-title":"Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma","volume":"36","author":"Roemer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1-2","key":"10.1053\/j.seminhematol.2024.05.001_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10428199909145944","article-title":"Major histocompatibility complex class II antigen presentation in Hodgkin's disease","volume":"36","author":"Bosshart","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"21","key":"10.1053\/j.seminhematol.2024.05.001_bib0024","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.2006.10.0917","article-title":"HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma","volume":"25","author":"Diepstra","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.05.001_bib0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/gene.2016.30","article-title":"CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse","volume":"17","author":"Abdul Razak","year":"2016","journal-title":"Genes Immun"},{"issue":"17","key":"10.1053\/j.seminhematol.2024.05.001_bib0026","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0027","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/cancers14051360","article-title":"The Hodgkin lymphoma immune microenvironment: turning bad news into good","volume":"14","author":"Men\u00e9ndez","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0028","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.seminhematol.2016.05.007","article-title":"Hodgkin lymphoma: pathology and biology","volume":"53","author":"Mathas","year":"2016","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.05.001_bib0029","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood.V59.2.226.226","article-title":"In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease","volume":"59","author":"Poppema","year":"1982","journal-title":"Blood"},{"issue":"21","key":"10.1053\/j.seminhematol.2024.05.001_bib0030","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood.2020005546","article-title":"Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58","volume":"136","author":"Veldman","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0031","first-page":"37","article-title":"Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428","volume":"48","author":"Sanders","year":"1988","journal-title":"Cancer Res"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.05.001_bib0032","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.05.001_bib0033","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nri.2017.118","article-title":"TH2 cell development and function","volume":"18","author":"Walker","year":"2018","journal-title":"Nature Rev Immunol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0034","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hon.878","article-title":"Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma","volume":"27","author":"Schreck","year":"2009","journal-title":"Hematol Oncol"},{"issue":"16","key":"10.1053\/j.seminhematol.2024.05.001_bib0035","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood-2013-06-508044","article-title":"Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells","volume":"122","author":"Greaves","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0036","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.2711","article-title":"The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape","volume":"221","author":"Aldinucci","year":"2010","journal-title":"J Pathol"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.05.001_bib0037","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2006-12-064360","article-title":"RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma","volume":"110","author":"Chemnitz","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.05.001_bib0038","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/0008-5472.CAN-05-3252","article-title":"Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma","volume":"66","author":"Chemnitz","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0039","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ijc.23119","article-title":"Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5\/Rantes in tumor cell growth and microenvironmental interactions","volume":"122","author":"Aldinucci","year":"2008","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0040","first-page":"837","article-title":"Analysis of CCL5 expression in classical Hodgkin's lymphoma L428 cell line","volume":"4","author":"Liu","year":"2011","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.05.001_bib0041","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.V94.6.2065","article-title":"Hodgkin\/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils","volume":"94","author":"Jundt","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0042","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/ijc.24389","article-title":"Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma","volume":"125","author":"Cattaruzza","year":"2009","journal-title":"Int J Cancer"},{"issue":"22","key":"10.1053\/j.seminhematol.2024.05.001_bib0043","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.05.001_bib0044","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1053\/j.seminhematol.2024.05.001_bib0045","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/bloodadvances.2017006346","article-title":"High proportions of PD-1(+) and PD-L1(+) leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome","volume":"1","author":"Hollander","year":"2017","journal-title":"Blood Adv"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.05.001_bib0046","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"New Engl J Med"},{"issue":"19","key":"10.1053\/j.seminhematol.2024.05.001_bib0047","first-page":"2343","article-title":"Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma","volume":"141","author":"Stewart","year":"2023","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.seminhematol.2024.05.001_bib0048","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood.2023019661","article-title":"Increasing microenvironment complexity in HL","volume":"141","author":"Chabay","year":"2023","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.05.001_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.964573","article-title":"Inflammatory microenvironment in classical Hodgkin's lymphoma with special stress on mast cells","volume":"12","author":"Ribatti","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2141.2002.03768.x","article-title":"Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma","volume":"119","author":"Molin","year":"2002","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0051","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3324\/haematol.2018.196725","article-title":"CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth","volume":"104","author":"Casagrande","year":"2019","journal-title":"Haematologica"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.05.001_bib0052","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3390\/ijms20102416","article-title":"Formation of the immunosuppressive microenvironment of classic Hodgkin lymphoma and therapeutic approaches to counter it","volume":"20","author":"Aldinucci","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1053\/j.seminhematol.2024.05.001_bib0053","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2014-05-576140","article-title":"Reed-Sternberg cell-derived lymphotoxin-\u03b1 activates endothelial cells to enhance T-cell recruitment in classical Hodgkin lymphoma","volume":"124","author":"Fhu","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0054","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1421889","article-title":"Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells","volume":"7","author":"Tosetti","year":"2018","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.05.001_bib0055","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2011-07-370841","article-title":"High ERp5\/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas","volume":"119","author":"Zocchi","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0056","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/0008-5472.CAN-06-2470","article-title":"ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro","volume":"67","author":"Eichenauer","year":"2007","journal-title":"Cancer Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0057","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3324\/haematol.2021.278469","article-title":"Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect","volume":"107","author":"Pece","year":"2022","journal-title":"Haematologica"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.05.001_bib0058","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00000478-200107000-00011","article-title":"TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma","volume":"25","author":"Peh","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0059","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2141.2007.06964.x","article-title":"Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22","volume":"140","author":"Niens","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/his.14836","article-title":"The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics","volume":"82","author":"Kilsdonk","year":"2023","journal-title":"Histopathology"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.05.001_bib0061","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0002-9440(10)65424-7","article-title":"High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma","volume":"154","author":"van den Berg","year":"1999","journal-title":"Am J Pathol"},{"issue":"22","key":"10.1053\/j.seminhematol.2024.05.001_bib0062","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.2023020959","article-title":"Elevated serum TARC levels precede classic Hodgkin lymphoma diagnosis by several years","volume":"142","author":"Diepstra","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0063","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3324\/haematol.2011.053199","article-title":"Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma","volume":"97","author":"Plattel","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0064","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bjh.16514","article-title":"Interim thymus and activation regulated chemokine versus interim (18) F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation","volume":"190","author":"Plattel","year":"2020","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0065","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1158\/1078-0432.CCR-12-2693","article-title":"Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma","volume":"19","author":"Jones","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.05.001_bib0066","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2004-09-3620","article-title":"Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas","volume":"106","author":"Mathas","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.05.001_bib0067","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2016.05.001","article-title":"NF-\u03baB deregulation in Hodgkin lymphoma","volume":"39","author":"Weniger","year":"2016","journal-title":"Semin Cancer Biol"},{"issue":"49","key":"10.1053\/j.seminhematol.2024.05.001_bib0068","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1038\/sj.onc.1203219","article-title":"How NF-\u03baB is activated: the role of the I\u03baB kinase (IKK) complex","volume":"18","author":"Karin","year":"1999","journal-title":"Oncogene"},{"issue":"49","key":"10.1053\/j.seminhematol.2024.05.001_bib0069","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1038\/sj.onc.1203224","article-title":"Regulation of DNA binding by Rel\/NF-kappaB transcription factors: structural views","volume":"18","author":"Chen","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2024.05.001_bib0070","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NF-kappaB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.05.001_bib0071","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1182\/blood.V87.10.4340.bloodjournal87104340","article-title":"High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin\/Reed-Sternberg cells","volume":"87","author":"Bargou","year":"1996","journal-title":"Blood"},{"issue":"33","key":"10.1053\/j.seminhematol.2024.05.001_bib0072","doi-asserted-by":"crossref","first-page":"27326","DOI":"10.1074\/jbc.M112.366658","article-title":"Structure of the nuclear factor \u03baB-inducing kinase (NIK) kinase domain reveals a constitutively active conformation","volume":"287","author":"Liu","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0073","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","article-title":"The noncanonical NF-\u03baB pathway","volume":"246","author":"Sun","year":"2012","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.05.001_bib0074","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119849","article-title":"Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells","volume":"100","author":"Bargou","year":"1997","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0075","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.onc.1202351","article-title":"Molecular mechanisms of constitutive NF-kappaB\/Rel activation in Hodgkin\/Reed-Sternberg cells","volume":"18","author":"Krappmann","year":"1999","journal-title":"Oncogene"},{"issue":"7247","key":"10.1053\/j.seminhematol.2024.05.001_bib0076","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0077","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.05.001_bib0078","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2141.2012.09113.x","article-title":"Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma","volume":"157","author":"Otto","year":"2012","journal-title":"Br J Haematol"},{"issue":"15","key":"10.1053\/j.seminhematol.2024.05.001_bib0079","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1182\/blood-2010-06-291310","article-title":"JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma","volume":"117","author":"Van Roosbroeck","year":"2011","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.seminhematol.2024.05.001_bib0080","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1182\/blood-2009-02-204842","article-title":"Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma","volume":"114","author":"Navarro","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0081","first-page":"549","article-title":"Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells","volume":"60","author":"Joos","year":"2000","journal-title":"Cancer Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0082","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/cancers13040682","article-title":"Genomic landscape of Hodgkin lymphoma","volume":"13","author":"Brune","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.05.001_bib0083","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"issue":"18","key":"10.1053\/j.seminhematol.2024.05.001_bib0084","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0085","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/blood.V98.3.762","article-title":"STAT3 is constitutively activated in Hodgkin cell lines","volume":"98","author":"Kube","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.05.001_bib0086","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1084\/jem.189.12.1939","article-title":"Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells","volume":"189","author":"Kapp","year":"1999","journal-title":"J Exp Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.05.001_bib0087","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/10428190290026259","article-title":"The role of interleukin 13 in classical Hodgkin lymphoma","volume":"43","author":"Skinnider","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.05.001_bib0088","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.05.001_bib0089","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1093\/emboj\/18.11.3064","article-title":"Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins","volume":"18","author":"Gires","year":"1999","journal-title":"EMBO J"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0091","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2005.05881.x","article-title":"Inhibition of the phosphatidylinositol-3 kinase\/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma","volume":"132","author":"Georgakis","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2024.05.001_bib0092","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2407-13-250","article-title":"Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease\u2014a combined tissue microarray, in vitro and in vivo study","volume":"13","author":"M\u00e1rk","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0093","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-020-00949-4","article-title":"The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy","volume":"13","author":"Yuan","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0094","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood-2002-11-3507","article-title":"MEK\/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival","volume":"102","author":"Zheng","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.humpath.2013.10.024","article-title":"c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma","volume":"45","author":"Leventaki","year":"2014","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0096","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":"Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","volume":"116","author":"Steidl","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0097","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V99.4.1381","article-title":"Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2","volume":"99","author":"Joos","year":"2002","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.05.001_bib0098","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood-2002-08-2577","article-title":"Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma","volume":"101","author":"Barth","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0099","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-09-3843","article-title":"Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma","volume":"108","author":"Martin-Subero","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.05.001_bib0100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.191.2.395","article-title":"Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma","volume":"191","author":"Jungnickel","year":"2000","journal-title":"J Exp Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0101","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.05.001_bib0102","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/biomedicines10092153","article-title":"NFkB pathway and Hodgkin lymphoma","volume":"10","author":"Jardin","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0103","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/path.1454","article-title":"Inactivating I kappa B epsilon mutations in Hodgkin\/Reed-Sternberg cells","volume":"201","author":"Emmerich","year":"2003","journal-title":"J Pathol"},{"issue":"22","key":"10.1053\/j.seminhematol.2024.05.001_bib0104","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.05.001_bib0105","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","article-title":"Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6","volume":"110","author":"Mottok","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0106","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.05.001_bib0107","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/blood-2016-06-720516","article-title":"A novel PTPN1 splice variant upregulates JAK\/STAT activity in classical Hodgkin lymphoma cells","volume":"129","author":"Zahn","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.05.001_bib0108","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"issue":"23","key":"10.1053\/j.seminhematol.2024.05.001_bib0109","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv"},{"issue":"7338","key":"10.1053\/j.seminhematol.2024.05.001_bib0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.05.001_bib0111","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","article-title":"Mass cytometry of Hodgkin lymphoma reveals a CD4(+) regulatory T-cell-rich and exhausted T-effector microenvironment","volume":"132","author":"Cader","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.05.001_bib0112","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","article-title":"PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma","volume":"111","author":"Yamamoto","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0113","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3324\/haematol.2022.280014","article-title":"PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion","volume":"108","author":"Taylor","year":"2023","journal-title":"Haematologica"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0114","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41408-019-0185-9","article-title":"Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma","volume":"9","author":"Jalali","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminhematol.2024.05.001_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101674","article-title":"Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France","volume":"54","author":"Donzel","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/pathogens7030059","article-title":"Contribution of Epstein-Barr virus latent proteins to the pathogenesis of classical Hodgkin lymphoma","volume":"7","author":"Vrzalikova","year":"2018","journal-title":"Pathogens"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.05.001_bib0117","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/v4091537","article-title":"Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival","volume":"4","author":"Frappier","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0118","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2353\/ajpath.2008.070845","article-title":"Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells","volume":"173","author":"Baumforth","year":"2008","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0119","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1128\/jvi.69.5.2968-2976.1995","article-title":"Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus","volume":"69","author":"Mitchell","year":"1995","journal-title":"J Virol"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0120","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.1725","article-title":"Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR","volume":"205","author":"Dutton","year":"2005","journal-title":"J Pathol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0121","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12935-021-01793-3","article-title":"Signaling pathways of EBV-induced oncogenesis","volume":"21","author":"Luo","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"42","key":"10.1053\/j.seminhematol.2024.05.001_bib0122","doi-asserted-by":"crossref","first-page":"26318","DOI":"10.1073\/pnas.2007946117","article-title":"Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A","volume":"117","author":"Fish","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.05.001_bib0123","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1182\/blood-2003-04-1018","article-title":"Epstein-Barr virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma","volume":"102","author":"Portis","year":"2003","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.seminhematol.2024.05.001_bib0124","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood-2014-08-594689","article-title":"Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1","volume":"125","author":"Lin","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.05.001_bib0125","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood.2019000568","article-title":"An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma","volume":"134","author":"Murray","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.05.001_bib0126","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3390\/cancers13123021","article-title":"Pitfalls in the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma: variant patterns, borderlines and mimics","volume":"13","author":"Younes","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0127","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/path.1746","article-title":"Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma","volume":"205","author":"Greiner","year":"2005","journal-title":"J Pathol"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.05.001_bib0128","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2002-05-1592","article-title":"Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma","volume":"101","author":"Wlodarska","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.05.001_bib0129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V87.2.465.bloodjournal872465","article-title":"Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease","volume":"87","author":"Falini","year":"1996","journal-title":"Blood"},{"issue":"17","key":"10.1053\/j.seminhematol.2024.05.001_bib0130","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","article-title":"Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells","volume":"94","author":"Braeuninger","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.05.001_bib0131","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.18376","article-title":"Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma","volume":"199","author":"Hartmann","year":"2022","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.05.001_bib0132","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis","volume":"205","author":"Brune","year":"2008","journal-title":"J Exp Med"},{"issue":"16","key":"10.1053\/j.seminhematol.2024.05.001_bib0133","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood-2015-08-665505","article-title":"Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution","volume":"127","author":"Kenderian","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.05.001_bib0134","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3324\/haematol.2021.278427","article-title":"Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation","volume":"106","author":"Paschold","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.05.001_bib0135","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/s41467-020-16375-6","article-title":"Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"11","author":"Thurner","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0136","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1053\/j.seminhematol.2024.05.001_bib0137","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1200\/JCO.2017.76.0793","article-title":"Nivolumab for relapsed\/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial","volume":"36","author":"Armand","year":"2018","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1053\/j.seminhematol.2024.05.001_bib0138","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood.2019000324","article-title":"Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087","volume":"134","author":"Chen","year":"2019","journal-title":"Blood"},{"issue":"20","key":"10.1053\/j.seminhematol.2024.05.001_bib0139","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1182\/bloodadvances.2023010334","article-title":"Nivolumab for relapsed\/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study","volume":"7","author":"Ansell","year":"2023","journal-title":"Blood Adv"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.05.001_bib0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJMoa2206125","article-title":"Overall survival with brentuximab vedotin in stage III or IV Hodgkin's lymphoma","volume":"387","author":"Ansell","year":"2022","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1053\/j.seminhematol.2024.05.001_bib0141","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1200\/JCO.2011.38.0410","article-title":"Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma","volume":"30","author":"Younes","year":"2012","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0142","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3324\/haematol.2017.180554","article-title":"A phase II study of the oral JAK1\/JAK2 inhibitor ruxolitinib in advanced relapsed\/refractory Hodgkin lymphoma","volume":"103","author":"Eric Van Den","year":"2018","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2024.05.001_bib0143","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-018-0103-z","article-title":"Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma","volume":"7","author":"Johnston","year":"2018","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.05.001_bib0144","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/1078-0432.CCR-16-1365","article-title":"Autologous T cells expressing CD30 chimeric antigen receptors for relapsed or refractory Hodgkin lymphoma: an open-label phase I trial","volume":"23","author":"Wang","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.05.001_bib0145","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1080\/10428194.2022.2095623","article-title":"AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial","volume":"63","author":"Sasse","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"21","key":"10.1053\/j.seminhematol.2024.05.001_bib0146","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood.2019004701","article-title":"A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma","volume":"136","author":"Bartlett","year":"2020","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.05.001_bib0147","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1158\/1078-0432.CCR-21-0164","article-title":"Combining AFM13, a bispecific CD30\/CD16 antibody, with cytokine-activated blood and cord blood-derived NK cells facilitates CAR-like responses against CD30(+) malignancies","volume":"27","author":"Kerbauy","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1053\/j.seminhematol.2024.05.001_bib0148","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood.2022017147","article-title":"Novel insights into Hodgkin lymphoma biology by single-cell analysis","volume":"141","author":"Aoki","year":"2023","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T13:04:50Z","timestamp":1726837490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196324000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":148,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0037196324000593"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.05.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The biology of classical Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}